CME Group Inc. (NASDAQ:CME) Shares Purchased by Boston Trust Walden Corp

Boston Trust Walden Corp raised its stake in shares of CME Group Inc. (NASDAQ:CME) by 1,417.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,634 shares of the financial services provider’s stock after buying an additional 14,604 shares during the period. Boston Trust Walden Corp’s holdings in CME Group were worth $3,450,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Oak Harvest Investment Services grew its stake in shares of CME Group by 66.5% in the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after purchasing an additional 18,017 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after purchasing an additional 8,443 shares during the last quarter. Duality Advisers LP acquired a new position in shares of CME Group in the 1st quarter worth approximately $1,455,000. SG Americas Securities LLC grew its stake in shares of CME Group by 312.2% in the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock worth $12,222,000 after purchasing an additional 42,996 shares during the last quarter. Finally, Cetera Investment Advisers grew its stake in shares of CME Group by 429.1% in the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after purchasing an additional 38,540 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ CME opened at $226.14 on Monday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a fifty day simple moving average of $218.94 and a 200 day simple moving average of $208.87. The company has a market cap of $81.43 billion, a P/E ratio of 25.73, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.25 EPS. On average, sell-side analysts predict that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CME shares. TD Cowen started coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective on the stock. Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Barclays lifted their target price on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday. Finally, Citigroup lifted their target price on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $222.07.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.